Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect and Safety of Limosilactobacillus Reuteri LM1063 Supplementation on the Improvement of Sleep Health: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

NCT07498712 is registered in ClinicalTrials.gov with Lactomason Co., Ltd. as lead sponsor.

NCT NCT07498712
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07498712 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect and Safety of Limosilactobacillus Reuteri LM1063 Supplementation on the Improvement of Sleep Health: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Lead sponsor
Lactomason Co., Ltd.
Phase
Not applicable
Overall status
Recruiting
Start date
July 14, 2025
Completion date
June 30, 2026
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sleep quality, sleep wake disorders